R
Remedy
Health Tech & Medtech · Austin, United States · Founded 2015
Top-rated urgent care service MoreLess
Remedy is a healthcare service provider specializing in on-demand urgent care through secure video consultations and house calls. Founded by Dr. Jeremy Gabrysch, the company aims to simplify access to effective medical care, particularly for those who want to avoid the high costs and long wait times associated with emergency rooms. Remedy operates primarily in Texas and serves a diverse range of clients, including individuals, families, and businesses. The business model involves a $49 dispatch fee at the time of booking, with all medical service charges billed to the patient's insurer. Remedy generates revenue through these fees and insurance reimbursements. The company also offers COVID-19 testing services and collaborates with employers to provide 24/7 healthcare access for their employees. Remedy's mission is to be the most trusted and beloved guide in healthcare, offering a seamless and efficient path to medical care.
Keywords: urgent care, video consultations, house calls, ER alternative, Texas, COVID-19 testing, insurance billing, healthcare access, employer services, on-demand medical care.
Company overview
Remedy company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Austin, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 58.3
Valuation & funding
Remedy funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2019 | $10M | $40M | Sante Ventures | — |
| EARLY VCEquity / VC | Apr 2018 | $0 | — | Undisclosed | — |
| EARLY VCEquity / VC | Jun 2017 | $1.8M | $7.2M | Undisclosed | — |
| ANGELEquity / VC | Feb 2016 | $750K | $3M | Undisclosed | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 24 |
| 2025 | 28 |
| 2024 | 18 |
| 2023 | 18 |
| 2022 | 11 |
| 2021 | 65 |
| 2020 | 67 |
Growth signals
Remedy website traffic
Latest recorded traffic for Remedy is 590 monthly website visits, down 25.3% over the last three months. Remedy's team declined 14.3% over the past year.
Comparisons
Remedy compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Remedy's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Remedy's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Remedy has talent and traffic
team presence
In the news
Latest news about Remedy
Recent press, funding announcements, and product moves mentioning Remedy — open to read from the original sources.
Market sentiment
What the market is saying about Remedy
An AI-synthesized read of the highest-engagement posts about Remedy on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Remedy’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.